---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-041392"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2023-12-13T23:59:59+00:00"
generated_at: "2026-06-07T13:53:04.931827+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Medifast enters medically supported weight loss market with $20M LifeMD deal; ends quarterly dividend

## Summary
- Medifast commits $20M to LifeMD ($10M platform contributions, $10M stock purchase) for collaboration.
- Discontinues quarterly cash dividend immediately to redirect capital to technology and growth initiatives.
- Launches OPTAVIA Nutrition Kit and Muscle Health Kit for medically supported weight loss patients.
- Medifast cites medically supported weight loss market projected up to $100B by 2030 as rationale.
- Collaboration integrates OPTAVIA coaches with LifeMD board-certified clinicians; pilot program completed.

## SEC filing metadata
- accession: 0001628280-23-041392
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2023-12-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828023041392/0001628280-23-041392-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828023041392/med-20231213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-041392
- JSON: https://secwatch.observer/filing/0001628280-23-041392.json
- Plain text: https://secwatch.observer/filing/0001628280-23-041392.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.